AVTX's three largest insider shareholders as of March 23, 2026 are Capital, Llc Armistice (Director, 162.92K shares), Garry Arthur Neil (Chief Executive Officer, 47.14K shares), Christopher Ryan Sullivan (Chief Financial Officer, 17.34K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Garry Arthur Neil | Chief Executive Officer | 47,140 | 0 | 01 Apr, 2025 |
| James Archie Jr Harrell | Chief Commercial Officer | 153 | 0 | 14 Dec, 2021 |
| H Jeffrey Wilkins | Chief Medical Officer | 139 | 0 | 14 Dec, 2021 |
| Christopher Ryan Sullivan | Chief Financial Officer | 17,338 | 0 | 12 Dec, 2025 |
| Schond L. Greenway | Cfo | 16 | 0 | 14 Dec, 2021 |
| Paul Varki | Chief Legal Officer | 3,634 | 0 | 12 Dec, 2025 |
| Mittie Doyle | Chief Medical Officer | 3,622 | 0 | 18 Mar, 2026 |
| Aaron Kantoff | 3,167 | 0 | 01 Apr, 2025 | |
| Mitchell Chan | 3,167 | 0 | 01 Apr, 2025 | |
| Samantha Truex | 3,167 | 0 | 01 Apr, 2025 | |
| Gilla Kaplan | 3,167 | 0 | 01 Apr, 2025 | |
| Jennifer Riley | Chief Strategy Officer | 2,655 | 0 | 12 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | Mittie Doyle | Common Stock | A | 19,500 | $12.65 | 23,122 | D | M |
| 16 Mar, 2026 | Mittie Doyle | Common Stock | A | 5,992 | $8.04 | 29,114 | D | M |
| 16 Mar, 2026 | Mittie Doyle | Common Stock | D | 25,492 | $16.15 | 3,622 | D | S |
| 16 Mar, 2026 | Mittie Doyle | Stock Option (Right to Buy) | D | 19,500 | $0.00 | 214,500 | D | M |
| 16 Mar, 2026 | Mittie Doyle | Stock Option (Right to Buy) | D | 5,992 | $0.00 | 149,008 | D | M |
| 26 Feb, 2026 | Christopher Ryan Sullivan | Stock Option (Right to Buy) | A | 105,000 | $0.00 | 105,000 | D | A |
| 26 Feb, 2026 | Paul Varki | Stock Option (Right to Buy) | A | 80,000 | $0.00 | 80,000 | D | A |
| 26 Feb, 2026 | Mittie Doyle | Stock Option (Right to Buy) | A | 105,000 | $0.00 | 105,000 | D | A |
| 26 Feb, 2026 | Garry Arthur Neil | Stock Option (Right to Buy) | A | 286,000 | $0.00 | 286,000 | D | A |
| 26 Feb, 2026 | Jennifer Riley | Stock Option (Right to Buy) | A | 95,000 | $0.00 | 95,000 | D | A |
| 26 Feb, 2026 | Taylor Boyd | Stock Option (Right to Buy) | A | 95,000 | $0.00 | 95,000 | D | A |
| 31 Dec, 2025 | Rita Jain | Stock Option (Right to Buy) | A | 1,043 | $14.74 | 1,043 | D | A |
| 31 Dec, 2025 | Kevin Robert Lind | Stock Option (Right to Buy) | A | 848 | $14.74 | 848 | D | A |
| 10 Dec, 2025 | Paul Varki | Common Stock | D | 1,016 | $4.10 | 3,634 | D | F |
| 10 Dec, 2025 | Christopher Ryan Sullivan | Common Stock | D | 155 | $4.10 | 17,338 | D | F |
| 10 Dec, 2025 | Mittie Doyle | Common Stock | D | 1,013 | $4.10 | 3,622 | D | F |
| 10 Dec, 2025 | Jennifer Riley | Common Stock | D | 637 | $4.10 | 2,655 | D | F |
| 14 Nov, 2025 | Jonathan Goldman | Common Stock | D | 3,167 | $14.30 | 0 | D | S |
| 14 Nov, 2025 | Jonathan Goldman | Common Stock | A | 8,200 | $9.88 | 8,200 | D | M |
| 14 Nov, 2025 | Jonathan Goldman | Common Stock | D | 8,200 | $14.35 | 0 | D | S |